Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vivus Inc.

www.vivus.com

Latest From Vivus Inc.

FDA Requests Belviq Be Pulled From The US Market Due To Cancer Risk

The agency requested the weight loss pill be voluntarily recalled by Eisai, the death knell for a trio of obesity drugs that launched early in the last decade. 
Metabolic Disorders Drug Safety

FDA Requests Belviq Be Pulled From The US Market Due To Cancer Risk

The agency requested the weight loss pill be voluntarily recalled by Eisai, the death knell for a trio of obesity drugs that launched early in the last decade. 
Metabolic Disorders Drug Safety

10 Drug Launch Flops Of The Decade

The view from 2020: Scrip looks back over the last decade at the drug launches that defied expectations – for the worse.

Launches Business Strategies

YouTube Video Suggesting Livalo Is Safer Than Other Statins Is Dinged By US FDA

Kowa Pharmaceuticals' patient testimonials implying switch from statins to Livalo will reduce drug side effects are misleading, untitled letter says.

Ad Complaints Advertising, Marketing & Sales
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Metabolic Disorders
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Vivus Inc.
  • Senior Management
  • Thomas B King, Interim CEO
    Mark K Oki, CFO & Chief Accounting Officer
    Deborah W Larsen, PhD, Chief Commercial Officer
    John L Slebir, SVP, Bus. Dev. & General Counsel
    Santosh T Varghese, MD, CMO
  • Contact Info
  • Vivus Inc.
    Phone: (650) 934-5200
    900 E. Hamilton Ave
    Suite 550
    Campbell, CA 95008
    USA
UsernamePublicRestriction

Register